S230. LONG-TERM ANTIPSYCHOTIC MEDICATION IN SCHIZOPHRENIA: BENEFITS, RISKS AND FOLLOW-UP: DATA FROM FINNISH COHORT STUDIES AND SYSTEMATIC REVIEW

BACKGROUND: Millions of people use antipsychotic medications. Thousands of clinicians (often non-psychiatrists) prescribe and monitor them every day. Existing research reports mostly favorable risk-benefit ratio during the first years of schizophrenia, but their risk-benefit ratio and maintenance ef...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Schizophr Bull
Main Authors: Isohanni, Matti, Miettunen, Jouko, Jääskeläinen, Erika, Moilanen, Jani, Hulkko, Anja, Huhtaniska, Sanna
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2018
Assuntos:
Abstracts
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5888038/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sby018.1017
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares